← Return to Bispecific antibodies For Multiple Myeloma
DiscussionBispecific antibodies For Multiple Myeloma
Blood Cancers & Disorders | Last Active: 1 day ago | Replies (5)Comment receiving replies
Replies to "@scottp777, it sounds like the trial drug helped you. Should treatment be necessary in the future..."
I am still eligible for Cart-T, and a host of other treatments. AMG701 was a bi-specific to BCMA/CD3, and since I responded well to it, there is an expectation that CART-T would work well also, should I need it in the future.